Advertisement

International Journal of Clinical Pharmacy

, Volume 38, Issue 5, pp 1103–1111 | Cite as

Potentially inappropriate medications in a sample of Portuguese nursing home residents: Does the choice of screening tools matter?

  • Filipa Alves da CostaEmail author
  • Catarina Periquito
  • Maria Clara Carneiro
  • Pedro Oliveira
  • Ana Isabel Fernandes
  • Patrícia Cavaco-Silva
Research Article

Abstract

Background Potentially inappropriate medications (PIMs) are often found in high proportion among the elderly population. The STOPP criteria have been suggested to detect more PIMs in European elderly than the Beers criteria. Objective This study aimed to determine the prevalence of PIMs and potential prescribing omissions (PPOs) in a sample of Portuguese nursing homes residents. Setting Four elderly facilities in mainland Portugal Method A descriptive cross-sectional study was used. Elderly polypharmacy patients were included in the study and their medication (registered in patient clinical records) analysed using the Beers (2012 original version and 2008 version adapted to Portugal), STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment) criteria. Data were analysed using univariate and bivariate descriptive statistics, considering a confidence interval of 95 %. Main outcome measures: Prevalence of PIMs and PPOs. Results The sample included 161 individuals, with a mean age of 84.7 years (SD = 6.35), 68.9 % being female. A total of 807 PIMs and 90 PPOs were identified through the application of the three set of criteria. The prevalence of PIMs using the most recent version of the Beers criteria was 85.1 and 42.1 % for independent and dependent of diagnosis, respectively. The Portuguese adaptation of this same tool indicated a lower prevalence of PIMs, 60.3 and 16.7 %, respectively. The prevalence of PIMs using the STOPP criteria was 75.4 %, whilst the prevalence of PPOs, using START, was 42.9 %. There were significant differences in the mean number of PIMs detected depending on the tool used. (p < 0.001). Conclusions The application of the studied criteria in an elderly sample enabled the identification of a notable amount of PIMs and PPOs, indicating there is room for improving the quality of care. The variation in prevalence indicates careful choice of the tool is a prerequisite for engaging in medication review. Using START/STOPP criteria enabled a more holistic approach to the quality of prescribing in the elderly, highlighting low levels of cardiovascular risk prevention and abuse of psychotropic drugs, aside with system failures largely preventable by electronic prescribing and alert generation.

Keywords

Beers criteria Inappropriate prescriptions Elderly Polypharmacy Pharmaceutical care Nursing homes STOPP criteria START criteria Prescribing omissions Medication review 

Notes

Acknowledgments

The authors wish to thank the people in charge of the elderly facilities that participated in this study and their clinical directors for their full support. We also acknowledge the important contribution of Lawrence Sturm in reviewing the English language.

Funding

The study did not receive any specific funding and all costs were entirely supported by Egas Moniz, Cooperativa de Ensino, SRL, located in Campus Universitário, Quinta da Granja, Monte da Caparica, Portugal.

Conflicts of interest

The authors declare that they have no financial or other relationships that might lead to a conflict of interest.

References

  1. 1.
    PORDATA. Indicadores de envelhecimento em Portugal. http://www.pordata.pt/Portugal/Indicadores+de+envelhecimento-526. Assessed 10 Oct 2014.
  2. 2.
    Borges EP, Morgado M, Macedo AF. Prescribing omissions in elderly patients admitted to a stroke unit: descriptive study using START criteria. Int J Clin Pharm. 2012;34(3):481–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Gallagher P, Barry PJ, O´Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113–21.CrossRefPubMedGoogle Scholar
  4. 4.
    Ryan C, O’Mahony D, Kennedy J, Weedle P, Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68(6):936–47.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    San-José A, Agustí A, Vidal X, Formiga F, López-Soto A, Fernández-Moyano A, et al. Inappropriate prescribing to older patients admitted to hospital: a comparison of different tools of misprescribing and underprescribing. Eur J Intern Med. 2014;25(8):710–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Liu CL, Peng LN, Chen YT, Lin MH, Liu LK, Chen LK. Potentially inappropriate prescribing (IP) for elderly medical inpatients in Taiwan: a hospital-based study. Arch Gerontol Geriatr. 2012;55(1):148–51.CrossRefPubMedGoogle Scholar
  7. 7.
    Retamal CG, Fernández RG, Espínola SF, Serrato AR, Ordóñez MA, Marín VP. Prevalence of potentially inappropriate medication in hospitalized elderly patients by using explicit criteria. Farm Hosp. 2014;38(4):305–16.Google Scholar
  8. 8.
    Hill-Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm and Ther. 2013;38(5):360–72.CrossRefGoogle Scholar
  9. 9.
    Gillespie U, Alassaad A, Hammarlund-Udenaes M, Mörlin C, Henrohn D, Bertilsson M, Melhus H. Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’ (MAI, STOPP and STARTs’) ability to predict hospitalization–analyses from a randomized controlled trial. PLoS ONE. 2013;8(5):e62401.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Karandikar YS, Chaudhari SR, Dalal NP, Sharma M, Pandit VA. Inappropriate prescribing in the elderly: a comparison of two validated screening tools. JCGG. 2013;4(4):109–14.Google Scholar
  11. 11.
    Beers MH, Ouslander J, Rollingher I, Reuben D, Brooks J, Beck J. Explicit criteria for determining in—appropriate medication use in nursing homes. Arch Intern Med. 1991;151(9):1825–32.CrossRefPubMedGoogle Scholar
  12. 12.
    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med. 1997;157(14):1531–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163(22):2716–24.CrossRefPubMedGoogle Scholar
  14. 14.
    Campanelli CM. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults: American Geriatrics Society 2012 Beers Criteria Update Expert Panel. J Am Geriatr Soc. 2012;60(4):616–31.CrossRefPubMedCentralGoogle Scholar
  15. 15.
    American Geriatrics Society 2015 Beers Criteria Update Expert Panel. American Geriatrics Society. Updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;2015(63):2227–46.CrossRefGoogle Scholar
  16. 16.
    Soares MA, Fernandez-Llimós F, Lança C, Cabrita J, Morais JA. Operacionalização para Portugal: Critérios de Beers de Medicamentos Inapropriados nos Doentes Idosos. Acta Med Port. 2008;21(5):441–52.PubMedGoogle Scholar
  17. 17.
    Cahir C, Moriarty F, Teljeur C, Fahey T, Bennett K. Potentially inappropriate prescribing and vulnerability and hospitalization in older community-dwelling patients. Ann Pharmacother. 2014;48(12):1546–54.CrossRefPubMedGoogle Scholar
  18. 18.
    Hudhra K, García-Caballos M, Jucja B, Casado-Fernández E, Espigares-Rodriguez E, Bueno-Cavanillas A. Frequency of potentially inappropriate prescriptions in older people at discharge according to Beers and STOPP criteria. Int J Clin Pharm. 2014;36(3):596–603.CrossRefPubMedGoogle Scholar
  19. 19.
    Miquel MD, Cuervo MS, Silveira ED, Machuca IS, González-Blazquez S, Errasquin BM, Cruz-Jentoft AJ. Potentially inappropriate drug prescription in older subjects across health care settings. Eur Geriatr Med. 2010;1(1):9–14.CrossRefGoogle Scholar
  20. 20.
    Lang PO, Hasso Y, Belmin J, Pavot I, Bayens JP, Vogt-Ferrier N, Gallagher P, O’Mahony D, Michel JP. STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people. Can J Public Health. 2009;100(6):426–31 [Article in French].PubMedGoogle Scholar
  21. 21.
    Delgado Silveira E, Montero Errasquín B, Muñoz-Garcia M, Vélez-Díaz-Pallarés M, Lozano Montoya I, Sánchez-Castellano C, et al. Improving drug prescribing in the elderly: a new edition of STOPP/START criteria. Esp Geriatr Gerontol. 2015;50(2):89–96 [Article in Spanish].CrossRefGoogle Scholar
  22. 22.
    Vermeulen Windsant-van den Tweel AM, Verduijn MM, Derijks HJ, van Marum RJ. Detection of inappropriate medication use in the elderly; will the STOPP and START criteria become the new Dutch standards? Ned Tijdschr Geneeskd. 2012;156(40):A5076 [Article in Dutch].PubMedGoogle Scholar
  23. 23.
    Morin L, Fastbom J, Laroche ML, Johnell K. Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates. Br J Clin Pharmacol. 2015;80(2):315–24.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Oliveira-Martins S, Soares MA, van Mil JWF, Cabrita J. Inappropriate drug use by Portuguese elderly outpatients—effects of the Beers criteria update. Pharm World Sci. 2006;28:296–301.CrossRefPubMedGoogle Scholar
  25. 25.
    Gouveia Pinto C, Carrageta MO, Miguel LS. Cost-effectiveness of rosuvastatin in the prevention of ischemic heart disease in Portugal. Value Health. 2008;11(2):154–9.CrossRefGoogle Scholar
  26. 26.
    Chang C-B, Chen J-H, Wen C-J, Kuo H-K, Lu I-S, Chiu L-S, Wu S-C, Chan D-C. Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria. Br J Clin Pharmacol. 2011;72(3):482–9.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Rocha O, Lunet N, Costa L, Barros H. Tratamento da osteoporose em Portugal: Tendência e variação geográfica. Acta Med Port. 2006;19:373–80.PubMedGoogle Scholar
  28. 28.
    Ravera S, Hummel SA, Stolk P, Heerdink RE, de Jong–van den Berg LTW, de Gier JJ. The use of driving impairing medicines: a European survey. Eur J Clin Pharmacol. 2009;65:1139–47.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Kojima G, Bell CL, Tamura B, Davis J, Inaba M, Masaki K. Combining quality improvement and geriatrics training: the nursing home polypharmacy outcomes project. Gerontol Geriatr Educ. 2014;35(4):395–408.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Pugh MJ, Hanlon JT, Zeber JE, et al. Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm. 2006;12:537.PubMedGoogle Scholar
  31. 31.
    Cahir C, Bennett K, Teljeur C, Fahey T. Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol. 2013;77(1):201–10.CrossRefPubMedCentralGoogle Scholar
  32. 32.
    O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Tommelein E, Petrovic M, Somers A, Mehuys E, van der Cammen T, Boussery K. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S) tool. J Public Health. 2016;38(2):e158–70.CrossRefGoogle Scholar
  34. 34.
    Costa FA, Duggan C, Bates I. Validation of a survey tool for use in cross-cultural studies. Pharm Pract (Internet). 2008;6(3):121–7.Google Scholar
  35. 35.
    Endres HG, Kaufmann-Kolle P, Steeb V, Bauer E, Böttner C, Thürmann P. Association between potentially inappropriate medication (PIM) use and risk of hospitalization in older adults: an observational study based on routine data comparing PIM use with use of PIM alternatives. PLoS ONE. 2016;11(2):e0146811. doi: 10.1371/journal.pone.0146811 CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Bjerre LM, Halil R, Catley C, Farrel B, Hogel M, Blacks C, et al. Potentially inappropriate prescribing (PIP) in long-term care (LTC) patients: validation of the 2014 STOPP–START and 2012 Beers criteria in a LTC population—a protocol for a cross-sectional comparison of clinical and health administrative data. BMJ Open. 2015;5:e009715. doi: 10.1136/bmjopen-2015009715.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing 2016

Authors and Affiliations

  1. 1.Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Superior de Ciências da Saúde Egas Moniz (ISCSEM)CaparicaPortugal
  2. 2.Epidemiology Department (ROR-Sul)Portuguese Institute of Oncology Lisbon Francisco Gentil (IPOLFG)LisbonPortugal
  3. 3.Pharmaceutical Society (OF)LisboaPortugal

Personalised recommendations